Dataset Information


P38 MAPK inhibition prevents polybrene-induced senescence of human mesenchymal stem cells during viral transduction.

ABSTRACT: The unique capacity of mesenchymal stem cells (MSCs) to migrate to the sites of damage, following intravenous transplantation, along with their proliferation and differentiation abilities make them promising candidates for MSC-based gene therapy. This therapeutic approach requires high efficacy delivery of stable transgenes to ensure their adequate expression in MSCs. One of the methods to deliver transgenes is via the viral transduction of MSCs. However, due to low transduction efficiency of MSCs, various polications are used to promote the association of viral particles with membranes of target cells. Among these polications polybrene is the most widely used one. Unfortunately, viral infection in presence of polybrene was shown to negatively affect proliferation rate of stem cells. The molecular mechanism underlying this effect is not yet uncovered. Therefore, the present study aimed to elucidate the mechanism of this phenomenon as well as to develop an effective approach to overcome the negative impact of polybrene on the properties of human endometrium-derived mesenchymal stem cells (hMESCs) during lentiviral infection. We found that the negative effect on proliferation observed during the viral infection in presence of polybrene is mediated by the polycation itself. Furthermore, we revealed that the treatment with polybrene alone led to the p38 MAPK-dependent premature senescence of hMESCs. These findings allowed us to develop an effective strategy to attenuate the negative polybrene impact on the hMESCs properties during lentiviral infection by inhibiting the activity of p38 MAPK. Importantly, the proposed approach did not attenuate the transduction efficiency of hMESCs, yet prevented polybrene-induced senescence and thereby restored the proliferation of the infected cells. These results provide the plausible means to reduce side effects of polybrene during the viral infection of primary cells, particularly MSCs.

SUBMITTER: Griukova A 

PROVIDER: S-EPMC6306270 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6006497 | BioStudies
1000-01-01 | S-EPMC5582306 | BioStudies
2014-01-01 | S-EPMC4055111 | BioStudies
2009-01-01 | S-EPMC2661103 | BioStudies
1000-01-01 | S-EPMC5845930 | BioStudies
2018-01-01 | S-EPMC6313978 | BioStudies
2020-01-01 | S-EPMC7374869 | BioStudies
2017-01-01 | S-EPMC5433165 | BioStudies
2020-01-01 | S-EPMC7217927 | BioStudies
2019-01-01 | S-EPMC6772136 | BioStudies